List of Excipients in API TRANYLCYPROMINE SULFATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TRANYLCYPROMINE SULFATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | ANHYDROUS CITRIC ACID | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CARNAUBA WAX | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CELLULOSE, MICROCRYSTALLINE | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | CROSCARMELLOSE SODIUM | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | D&C RED NO. 7 | |
| Actavis Pharma Inc | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | 0591-5590 | FD&C BLUE NO. 2 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing TRANYLCYPROMINE SULFATE
Detailed excipient profiles for TRANYLCYPROMINE SULFATE
Excipient focus: ANHYDROUS CITRIC ACID
TRANYLCYPROMINE SULFATE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CALCIUM SULFATE
TRANYLCYPROMINE SULFATE drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing CALCIUM SULFATE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
TRANYLCYPROMINE SULFATE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CARNAUBA WAX
TRANYLCYPROMINE SULFATE drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TRANYLCYPROMINE SULFATE drug variants containing CELLULOSE, MICROCRYSTALLINE
TRANYLCYPROMINE SULFATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
TRANYLCYPROMINE SULFATE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
TRANYLCYPROMINE SULFATE drug variants containing CROSCARMELLOSE SODIUM
TRANYLCYPROMINE SULFATE drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
TRANYLCYPROMINE SULFATE drug variants containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing D&C RED NO. 7
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
TRANYLCYPROMINE SULFATE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
TRANYLCYPROMINE SULFATE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
TRANYLCYPROMINE SULFATE drug variants containing FD&C RED NO. 40
TRANYLCYPROMINE SULFATE drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
TRANYLCYPROMINE SULFATE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
TRANYLCYPROMINE SULFATE drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing GELATIN
Excipient focus: HYPROMELLOSE
TRANYLCYPROMINE SULFATE drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
TRANYLCYPROMINE SULFATE drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE
TRANYLCYPROMINE SULFATE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing LACTOSE
Excipient focus: MAGNESIUM STEARATE
TRANYLCYPROMINE SULFATE drug variants containing MAGNESIUM STEARATE
TRANYLCYPROMINE SULFATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
TRANYLCYPROMINE SULFATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
TRANYLCYPROMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
TRANYLCYPROMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
TRANYLCYPROMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
TRANYLCYPROMINE SULFATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
TRANYLCYPROMINE SULFATE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | tranylcypromine sulfate | 49884-032 |
| Golden State Medical Supply Inc | tranylcypromine sulfate | 60429-210 |
| Bryant Ranch Prepack | tranylcypromine sulfate | 63629-2247 |
| Strides Pharma Science Limited | tranylcypromine sulfate | 64380-176 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | tranylcypromine sulfate | 0591-5590 |
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| Advanz Pharma (US) Corp | tranylcypromine sulfate | 59212-447 |
| Rising Pharmaceuticals Inc | tranylcypromine sulfate | 64980-183 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
TRANYLCYPROMINE SULFATE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | tranylcypromine sulfate | 47781-517 |
| >Company | >Ingredient | >NDC |
TRANYLCYPROMINE SULFATE drug variants not containing STARCH, CORN
Excipient focus: TALC
TRANYLCYPROMINE SULFATE drug variants containing TALC
TRANYLCYPROMINE SULFATE drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
TRANYLCYPROMINE SULFATE drug variants containing TITANIUM DIOXIDE
TRANYLCYPROMINE SULFATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
